Robert Califf, FDA commissioner (Michael Brochstein/Sipa USA/Sipa via AP Images)
Biotech, academic leaders encourage FDA to consider T-cell assessment in Covid-19 vaccine trials
More than 60 signatories sent a letter to the FDA’s Robert Califf and Peter Marks on Thursday urging the agency to include a recommendation for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
